Hearing implant maker Cochlear Ltd. (ASX:COH) has seen shares rise nearly 4% after the company won FDA approval for its Nucleus 7 sound processor, according to a Motley Fool Australia report. The newly cleared N7 processor is superior to its prior N6 version, and is compatible with Apple’s iOS, while its telecoil is optimized for loops, according […]
Cochlear Ltd.
Cochlear dips on slumping China sales
(Reuters) — Cochlear Ltd. (ASX:COH), the world #1 hearing implants maker, yesterday posted record half-year profits on a robust U.S. sales, but a slump in China tender orders pushed its share price more than 3% lower when the market closed Down Under. Although Cochlear has come back from a damaging recall in 2011 to book strong results over the […]
Appeals court reverses Cochlear win in Advanced Bionics patent spat
A federal appeals court last week overturned a win for Cochlear Ltd. (ASX:COH) in its patent spat with Advanced Bionics over hearing implant technology, sending the case back to district court for reconsideration in light of a recent U.S. Supreme Court decision. The cochlear implant patents were licensed to Advanced Bionics by the Alfred E. Mann Foundation, named […]
FDA approves Cochlear’s Nucleus MRI-safe implant
Cochlear Ltd. (ASX:COH) said today it won FDA premarket approval for its magnetic resonance imaging-compatible Nucleus cochlear implant. The devices won clearance for use with up to 3.0T MRI machines with the unit’s magnet removed, and up to 1.5T machines with the use of the Centennial, Colo.-based company’s Cochlear Nucleus Implant Bandage and Splint Kit “Cochlear has […]
Cochlear shares dip despite huge gains in profit for FY2016
Cochlear Ltd. (ASX:COH) saw shares sag despite releasing fiscal year 2016 earnings today that showed annual net profit growing 30% while overall sales were up almost 25%. The Australian hearing aid giant reported profits of $144.9 million, or $2.54 per share, on sales of $888.6 million for the full 2016 fiscal year. That amounts to a […]
Medtronic, Cochlear get in on $51m Earlens round
Earlens said today that it raised a funding round worth $51 million for the light-driven hearing aid it developed, pulling down $34 million in cash and another $17 million in a bridge financing conversion. The Earlens device, which last October won 510(k) clearance from the FDA, uses a laser diode attached to a behind-the-ear audio processor to […]
Cochlear wins FDA clearance for Baja 5 SuperPower sound processor
Cochlear Ltd. (ASX:COH) said today that the FDA cleared its Baha 5 SuperPower sound processor, which is designed to treat higher degrees of mixed hearing loss. The device allows users to stream audio directly from Apple devices including the iPhone, iPod Touch and iPad, via Bluetooth, the Centennial, Colo.-based company said. “The FDA clearance of the […]
Australia’s Cochlear wants to buy govt hearing service, raises profit outlook on soaring Chinese sales
(Reuters) – The Australian government said it is weighing a proposal from a consortium including hearing implant maker Cochlear Ltd. (ASX:COH) to buy a state-owned hearing service, a move likely to create headwinds from an electorate sensitive to privatised health. In a statement on Friday, Finance Minister Mathias Cormann said the government was approached by a […]
Report: AdvaMed CEO Ubl to leave for top spot at PhHRMA | Personnel Moves
Steve Ubl, the longtime CEO at medical device lobby AdvaMed, is reportedly leaving the organization after 17 years to take the top spot at the pharmaceutical industry’s largest trade group, the Pharmaceutical Research and Manufacturers of America or PhRMA. The Hill, citing an unnamed source, said that Ubl “will more than likely” take over as […]
Zimmer & Biomet shift personnel after acquisition| Personnel Moves
Zimmer (NYSE:ZMH), who acquired Biomet in a deal that closed this month, announced a series of personnel shifts upon the closure of the merger. Zimmer CFO and senior veep James Crines has stepped down from his position to retire, effective August 3, to be replaced by former CFO and senior veep of BiometDaniel Florin, the company said. […]